OmniComm Systems, Inc. (OMCM) CRO Preferred Program Adds Veeda Oncology
OmniComm Systems is a provider of customer-driven Internet solutions to pharmaceutical, biotechnology, research, and medical device organizations that conduct clinical trial research both in the United States and Europe. It is one of the fastest growing companies in electronic data capture (EDC) marketplace today. The company today announced that Veeda Clinical Research, Inc., also known as Veeda Oncology, has joined OmniComm's CRO Preferred Program. As part of this program, Veeda Oncology has signed an agreement to run their first study through the program, a 27-month, phase I oncology trial. This complex study will utilize OmniComm's TrailMaster EDC suite to manage…